0
2022
Radiation Oncology Market

Radiation Oncology Market

by Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy), by Application (Prostate Cancer, Breast Cancer, Lung Cancer, Head and Neck Cancer, Colorectal Cancer, Cervical Cancer, Gynecological Cancer, Others): Global Opportunity Analysis and Industry Forecast, 2021-2030

Report Code: A18438
Jul 2022 | Pages: 280
Tables: 126
Charts: 66
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

Radiation Oncology Market Research, 2030

The global radiation oncology market size was valued at $7.79 billion in 2021, and is projected to reach $15.23 billion by 2030, growing at a CAGR of 7.8% from 2022 to 2030. Radiotherapy is used to treat cancer by radiating the tumour cells and destructing its growth and division procedure the rising incidence and prevalence of cancer, the growing awareness of radiotherapy's therapeutic benefits, and technological developments in the field of radiotherapy are the main factors driving this market's expansion. The use of radiotherapy is also being boosted by significant opportunities presented by emerging economies and rising government spending on cancer treatment. Radiation therapy persists as an important part of treatment with nearly 50% of cancer patients receiving it and with a contribution of 40% of the curative treatment.

The health-care sector was severely damaged by the coronavirus epidemic in 2019. The pandemic has had an impact on the economics of radiation therapy delivery, even though much of the study has concentrated on the direct costs of preventing and treating COVID-19.

Radiation Oncology Market, Radiation Oncology Market size, Radiation Oncology Market share, Radiation Oncology Market trends, Radiation Oncology Market growth, Radiation Oncology Market forecast, Radiation Oncology Market analysis, Radiation Oncology Market opportunity

Some of the key factors driving the market include the rising incidence of cancer, the rising use of radiotherapy in cancer treatment, and technological developments in radiotherapy equipment. The radiation oncology market is anticipated to be driven by technological developments to increase treatment efficacy and safety. A combination of 4D imaging and radiotherapy, known as 4D radiotherapy, enables real-time tumour tracking and provides precise data on the tumour's size, shape, area, and volume. With the help of this combination, doctors can deliver a conformal dose while compensating for organ, tumour, or patient movement. These factors are anticipated to propel the global radiation oncology market share.

But one of the main things holding back the market for radiation oncology is the scarcity of qualified radiotherapy specialists. For instance, while Bangladesh reports only 0.76 radiation oncologists per 1,000 cancer patients, developed nations typically have 2-3 radiation oncologists for every 1,000 cancer patients. The situation in India is comparable. In addition, physicians in many nations lack exposure to and education in radiation oncology.

It is anticipated that access to high-quality healthcare will improve in several emerging nations, including China, India, Brazil, and Mexico, due to their rapid economic development and rising healthcare spending. This is thought to be a promising sign for the radiation oncology market. The demand for various radiotherapy devices and techniques is increasing as a result of the rising cancer incidence in these nations. Additionally, governments in each of these nations are concentrating on expanding access to high-quality healthcare services for more of their citizens as well as expanding the scope of reimbursement. The expansion of healthcare products (including oncology devices) across these countries is being driven by the quick increase in per-capita healthcare spending and the rising public demand for affordable healthcare services. The aforementioned factors are boosting the radiation oncology market growth.

The key players in the global radiation oncology market are Varian Medical Systems, Inc., Elekta AB, Accuray Incorporated, Mevion Medical Systems, IBA Worldwide, Nordion (Canada) Inc., BD, Isoray Inc., Provision Healthcare, and Panacea Medical Technologies Pvt. Ltd.

The global radiation oncology market is segmented on the basis of type, application and regional analysis. On basis of type, they are further sub-segmented into external beam radiation therapy and internal beam radiation therapy. On basis of application, they are further sub-segmented into prostate cancer, breast cancer, lung cancer, head & neck cancer, colorectal cancer, cervical cancer, gynecological cancer, and others. On basis of region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The radiation oncology market is segmented into Type and Application.

Radiation Oncology Market

By type, the external beam radiation therapy sub-segment accounted for highest revenue share and expected to generate the highest revenue in the timeframe. High adoption rate of external beam radiation therapy by the healthcare professionals owing to its high accuracy in targeting abnormal cells and reducing pain in advanced cancers. The external beam radiation therapy has better accuracy to target the tumor to destroy the abnormal cells and alleviate pain. The therapy uses a special X-Ray machine called a linear accelerator to deliver high energy rays to tumors. Thus, adoption of the external beam radiation therapy is increasing day by day by the oncologist. This factor is predicted to fuel revenue growth of the market in the review time.

Radiation Oncology Market

By application, the breast cancer application sub-segment accounted for the highest market size. Increasing prevalence of breast cancer especially in developed countries as a result of aging, obesity, and radiation exposure is estimated to drive the sub-segment growth in the analysis time. According to the American Cancer Society, a nationwide voluntary health organization, breast cancer is the second leading cause of cancer death in women. The chances that a woman will die from breast cancer is about 1 in 39 (about 2.6%). Breast cancer is increasing due to aging, obesity, and exposure to radiation. Increase in number of cases of breast cancer is rising the demand for radiation therapy. This factor is estimated to increase the demand for radiotherapy, which is estimated to drive the market growth in the review time.

Radiation Oncology Market

By region, the North America region has a major share in the radiation oncology market, accounting for over 43.7%, and is expected to maintain its dominance in the coming years. The presence of the most sophisticated and advanced healthcare infrastructure in North America, particularly in the U.S., is driving cancer patients in these locations to adopt radiation oncology procedures. Rising prevalence of breast cancer, particularly in developed countries in the region, as a result of aging, obesity, and radiation exposure, is expected to drive market growth during the forecast period. Furthermore, the U.S. Department of Health and Human Services has recently introduced nine federal programs to encourage cancer prevention and early detection by giving additional funding for better cancer treatment methods, which is expected to drive the market revenue growth in the near future.

Impact of COVID-19 on the Global Radiation Oncology Industry

  • The Covid-19 pandemic outbreak impacted many industries. Even though healthcare industries were favoured by the pandemic, not every part was positively impacted. Many clinics all across the world were converted to Covid-19 clinics to treat the affected patients.
  • Covid infected patients were on priority and unavailability of hospitals and surgeons was a major restrain for the radiation oncology market. Patients avoided hospitals in fear of infection.
  • When compared to the same months in 2019, typical weekly radiotherapy courses dropped by 19.9% in April, 6.2% in May, and 11.6% in June in 2020. However, there has been a rise in the patients taking radiotherapy treatments as the restrictions have been removed and markets have started opening to masses. Patients now no longer hesitate to visit the hospitals and very soon a recovery can be visible in the global radiotherapy market.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the radiation oncology market analysis from 2021 to 2030 to identify the prevailing radiation oncology market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and radiation oncology market opportunity over the coming years.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the radiation oncology market forecast, segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global radiation oncology market trends, key players, market segments, application areas, and market growth strategies.

Radiation Oncology Market Report Highlights

Aspects Details
By Type
  • External Beam Radiation Therapy
  • Internal Beam Radiation Therapy
By Application
  • Prostate Cancer
  • Breast Cancer
  • Lung Cancer
  • Head and Neck Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Gynecological Cancer
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, United Kingdom, France, Spain, Italy, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest Of Asia Pacific)
  • LAMEA  (Brazil, Saudi Arabia, UAE, South Africa, Rest of LAMEA)
Key Market Players BD, Nordion (Canada) Inc., IBA Worldwide, Elekta AB, Accuray Incorporated, Panacea Medical Technologies Pvt. Ltd, Isoray Inc., Varian Medical Systems, Inc., Provision Healthcare, Mevion Medical Systems
 
  • CHAPTER 1:INTRODUCTION

    • 1.1.Report description

    • 1.2.Key market segments

    • 1.3.Key benefits to the stakeholders

    • 1.4.Research Methodology

      • 1.4.1.Secondary research

      • 1.4.2.Primary research

      • 1.4.3.Analyst tools and models

  • CHAPTER 2:EXECUTIVE SUMMARY

    • 2.1.Key findings of the study

    • 2.2.CXO Perspective

  • CHAPTER 3:MARKET OVERVIEW

    • 3.1.Market definition and scope

    • 3.2.Key findings

      • 3.2.1.Top investment pockets

    • 3.3.Porter’s five forces analysis

    • 3.4.Top player positioning

    • 3.5.Market dynamics

      • 3.5.1.Drivers

      • 3.5.2.Restraints

      • 3.5.3.Opportunities

    • 3.6.COVID-19 Impact Analysis on the market

    • 3.7.Value Chain Analysis

    • 3.8.Market Share Analysis

    • 3.9.Regulatory Guidelines

    • 3.10.Key Regulation Analysis

    • 3.11.Patent Landscape

  • CHAPTER 4: RADIATION ONCOLOGY MARKET, BY TYPE

    • 4.1 Overview

      • 4.1.1 Market size and forecast

    • 4.2 External Beam Radiation Therapy

      • 4.2.1 Key market trends, growth factors and opportunities

      • 4.2.2 Market size and forecast, by region

      • 4.2.3 Market analysis by country

    • 4.3 Internal Beam Radiation Therapy

      • 4.3.1 Key market trends, growth factors and opportunities

      • 4.3.2 Market size and forecast, by region

      • 4.3.3 Market analysis by country

  • CHAPTER 5: RADIATION ONCOLOGY MARKET, BY APPLICATION

    • 5.1 Overview

      • 5.1.1 Market size and forecast

    • 5.2 Prostate Cancer

      • 5.2.1 Key market trends, growth factors and opportunities

      • 5.2.2 Market size and forecast, by region

      • 5.2.3 Market analysis by country

    • 5.3 Breast Cancer

      • 5.3.1 Key market trends, growth factors and opportunities

      • 5.3.2 Market size and forecast, by region

      • 5.3.3 Market analysis by country

    • 5.4 Lung Cancer

      • 5.4.1 Key market trends, growth factors and opportunities

      • 5.4.2 Market size and forecast, by region

      • 5.4.3 Market analysis by country

    • 5.5 Head and Neck Cancer

      • 5.5.1 Key market trends, growth factors and opportunities

      • 5.5.2 Market size and forecast, by region

      • 5.5.3 Market analysis by country

    • 5.6 Colorectal Cancer

      • 5.6.1 Key market trends, growth factors and opportunities

      • 5.6.2 Market size and forecast, by region

      • 5.6.3 Market analysis by country

    • 5.7 Cervical Cancer

      • 5.7.1 Key market trends, growth factors and opportunities

      • 5.7.2 Market size and forecast, by region

      • 5.7.3 Market analysis by country

    • 5.8 Gynecological Cancer

      • 5.8.1 Key market trends, growth factors and opportunities

      • 5.8.2 Market size and forecast, by region

      • 5.8.3 Market analysis by country

    • 5.9 Others

      • 5.9.1 Key market trends, growth factors and opportunities

      • 5.9.2 Market size and forecast, by region

      • 5.9.3 Market analysis by country

  • CHAPTER 6: RADIATION ONCOLOGY MARKET, BY REGION

    • 6.1 Overview

      • 6.1.1 Market size and forecast

    • 6.2 North America

      • 6.2.1 Key trends and opportunities

      • 6.2.2 North America Market size and forecast, by Type

      • 6.2.3 North America Market size and forecast, by Application

      • 6.2.4 North America Market size and forecast, by country

        • 6.2.4.1 U.S.
          • 6.2.4.1.1 Market size and forecast, by Type
          • 6.2.4.1.2 Market size and forecast, by Application
        • 6.2.4.2 Canada
          • 6.2.4.2.1 Market size and forecast, by Type
          • 6.2.4.2.2 Market size and forecast, by Application
        • 6.2.4.3 Mexico
          • 6.2.4.3.1 Market size and forecast, by Type
          • 6.2.4.3.2 Market size and forecast, by Application
    • 6.3 Europe

      • 6.3.1 Key trends and opportunities

      • 6.3.2 Europe Market size and forecast, by Type

      • 6.3.3 Europe Market size and forecast, by Application

      • 6.3.4 Europe Market size and forecast, by country

        • 6.3.4.1 Germany
          • 6.3.4.1.1 Market size and forecast, by Type
          • 6.3.4.1.2 Market size and forecast, by Application
        • 6.3.4.2 United Kingdom
          • 6.3.4.2.1 Market size and forecast, by Type
          • 6.3.4.2.2 Market size and forecast, by Application
        • 6.3.4.3 France
          • 6.3.4.3.1 Market size and forecast, by Type
          • 6.3.4.3.2 Market size and forecast, by Application
        • 6.3.4.4 Spain
          • 6.3.4.4.1 Market size and forecast, by Type
          • 6.3.4.4.2 Market size and forecast, by Application
        • 6.3.4.5 Italy
          • 6.3.4.5.1 Market size and forecast, by Type
          • 6.3.4.5.2 Market size and forecast, by Application
        • 6.3.4.6 Rest of Europe
          • 6.3.4.6.1 Market size and forecast, by Type
          • 6.3.4.6.2 Market size and forecast, by Application
    • 6.4 Asia-Pacific

      • 6.4.1 Key trends and opportunities

      • 6.4.2 Asia-Pacific Market size and forecast, by Type

      • 6.4.3 Asia-Pacific Market size and forecast, by Application

      • 6.4.4 Asia-Pacific Market size and forecast, by country

        • 6.4.4.1 China
          • 6.4.4.1.1 Market size and forecast, by Type
          • 6.4.4.1.2 Market size and forecast, by Application
        • 6.4.4.2 Japan
          • 6.4.4.2.1 Market size and forecast, by Type
          • 6.4.4.2.2 Market size and forecast, by Application
        • 6.4.4.3 India
          • 6.4.4.3.1 Market size and forecast, by Type
          • 6.4.4.3.2 Market size and forecast, by Application
        • 6.4.4.4 South Korea
          • 6.4.4.4.1 Market size and forecast, by Type
          • 6.4.4.4.2 Market size and forecast, by Application
        • 6.4.4.5 Australia
          • 6.4.4.5.1 Market size and forecast, by Type
          • 6.4.4.5.2 Market size and forecast, by Application
        • 6.4.4.6 Rest Of Asia Pacific
          • 6.4.4.6.1 Market size and forecast, by Type
          • 6.4.4.6.2 Market size and forecast, by Application
    • 6.5 LAMEA

      • 6.5.1 Key trends and opportunities

      • 6.5.2 LAMEA Market size and forecast, by Type

      • 6.5.3 LAMEA Market size and forecast, by Application

      • 6.5.4 LAMEA Market size and forecast, by country

        • 6.5.4.1 Brazil
          • 6.5.4.1.1 Market size and forecast, by Type
          • 6.5.4.1.2 Market size and forecast, by Application
        • 6.5.4.2 Saudi Arabia
          • 6.5.4.2.1 Market size and forecast, by Type
          • 6.5.4.2.2 Market size and forecast, by Application
        • 6.5.4.3 UAE
          • 6.5.4.3.1 Market size and forecast, by Type
          • 6.5.4.3.2 Market size and forecast, by Application
        • 6.5.4.4 South Africa
          • 6.5.4.4.1 Market size and forecast, by Type
          • 6.5.4.4.2 Market size and forecast, by Application
        • 6.5.4.5 Rest of LAMEA
          • 6.5.4.5.1 Market size and forecast, by Type
          • 6.5.4.5.2 Market size and forecast, by Application
  • CHAPTER 7: COMPANY LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top winning strategies

    • 7.3. Product Mapping of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Key developments

  • CHAPTER 8: COMPANY PROFILES

    • 8.1 BD

      • 8.1.1 Company overview

      • 8.1.2 Company snapshot

      • 8.1.3 Operating business segments

      • 8.1.4 Product portfolio

      • 8.1.5 Business performance

      • 8.1.6 Key strategic moves and developments

    • 8.2 Isoray Inc.

      • 8.2.1 Company overview

      • 8.2.2 Company snapshot

      • 8.2.3 Operating business segments

      • 8.2.4 Product portfolio

      • 8.2.5 Business performance

      • 8.2.6 Key strategic moves and developments

    • 8.3 Provision Healthcare

      • 8.3.1 Company overview

      • 8.3.2 Company snapshot

      • 8.3.3 Operating business segments

      • 8.3.4 Product portfolio

      • 8.3.5 Business performance

      • 8.3.6 Key strategic moves and developments

    • 8.4 Varian Medical Systems, Inc.

      • 8.4.1 Company overview

      • 8.4.2 Company snapshot

      • 8.4.3 Operating business segments

      • 8.4.4 Product portfolio

      • 8.4.5 Business performance

      • 8.4.6 Key strategic moves and developments

    • 8.5 Elekta AB

      • 8.5.1 Company overview

      • 8.5.2 Company snapshot

      • 8.5.3 Operating business segments

      • 8.5.4 Product portfolio

      • 8.5.5 Business performance

      • 8.5.6 Key strategic moves and developments

    • 8.6 Accuray Incorporated

      • 8.6.1 Company overview

      • 8.6.2 Company snapshot

      • 8.6.3 Operating business segments

      • 8.6.4 Product portfolio

      • 8.6.5 Business performance

      • 8.6.6 Key strategic moves and developments

    • 8.7 Mevion Medical Systems

      • 8.7.1 Company overview

      • 8.7.2 Company snapshot

      • 8.7.3 Operating business segments

      • 8.7.4 Product portfolio

      • 8.7.5 Business performance

      • 8.7.6 Key strategic moves and developments

    • 8.8 IBA Worldwide

      • 8.8.1 Company overview

      • 8.8.2 Company snapshot

      • 8.8.3 Operating business segments

      • 8.8.4 Product portfolio

      • 8.8.5 Business performance

      • 8.8.6 Key strategic moves and developments

    • 8.9 Nordion (Canada) Inc.

      • 8.9.1 Company overview

      • 8.9.2 Company snapshot

      • 8.9.3 Operating business segments

      • 8.9.4 Product portfolio

      • 8.9.5 Business performance

      • 8.9.6 Key strategic moves and developments

    • 8.10 Panacea Medical Technologies Pvt. Ltd

      • 8.10.1 Company overview

      • 8.10.2 Company snapshot

      • 8.10.3 Operating business segments

      • 8.10.4 Product portfolio

      • 8.10.5 Business performance

      • 8.10.6 Key strategic moves and developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL RADIATION ONCOLOGY MARKET, BY TYPE, 2021-2030,($MILLION)
    TABLE 2. RADIATION ONCOLOGY MARKET REVENUE, FOR EXTERNAL BEAM RADIATION THERAPY, BY REGION , 2021-2030,($MILLION)
    TABLE 3. RADIATION ONCOLOGY MARKET FOR EXTERNAL BEAM RADIATION THERAPY BY COUNTRY, 2021-2030,($MILLION)
    TABLE 4. RADIATION ONCOLOGY MARKET REVENUE, FOR INTERNAL BEAM RADIATION THERAPY, BY REGION , 2021-2030,($MILLION)
    TABLE 5. RADIATION ONCOLOGY MARKET FOR INTERNAL BEAM RADIATION THERAPY BY COUNTRY, 2021-2030,($MILLION)
    TABLE 6. GLOBAL RADIATION ONCOLOGY MARKET, BY APPLICATION, 2021-2030,($MILLION)
    TABLE 7. RADIATION ONCOLOGY MARKET REVENUE, FOR PROSTATE CANCER, BY REGION , 2021-2030,($MILLION)
    TABLE 8. RADIATION ONCOLOGY MARKET FOR PROSTATE CANCER BY COUNTRY, 2021-2030,($MILLION)
    TABLE 9. RADIATION ONCOLOGY MARKET REVENUE, FOR BREAST CANCER, BY REGION , 2021-2030,($MILLION)
    TABLE 10. RADIATION ONCOLOGY MARKET FOR BREAST CANCER BY COUNTRY, 2021-2030,($MILLION)
    TABLE 11. RADIATION ONCOLOGY MARKET REVENUE, FOR LUNG CANCER, BY REGION , 2021-2030,($MILLION)
    TABLE 12. RADIATION ONCOLOGY MARKET FOR LUNG CANCER BY COUNTRY, 2021-2030,($MILLION)
    TABLE 13. RADIATION ONCOLOGY MARKET REVENUE, FOR HEAD AND NECK CANCER, BY REGION , 2021-2030,($MILLION)
    TABLE 14. RADIATION ONCOLOGY MARKET FOR HEAD AND NECK CANCER BY COUNTRY, 2021-2030,($MILLION)
    TABLE 15. RADIATION ONCOLOGY MARKET REVENUE, FOR COLORECTAL CANCER, BY REGION , 2021-2030,($MILLION)
    TABLE 16. RADIATION ONCOLOGY MARKET FOR COLORECTAL CANCER BY COUNTRY, 2021-2030,($MILLION)
    TABLE 17. RADIATION ONCOLOGY MARKET REVENUE, FOR CERVICAL CANCER, BY REGION , 2021-2030,($MILLION)
    TABLE 18. RADIATION ONCOLOGY MARKET FOR CERVICAL CANCER BY COUNTRY, 2021-2030,($MILLION)
    TABLE 19. RADIATION ONCOLOGY MARKET REVENUE, FOR GYNECOLOGICAL CANCER, BY REGION , 2021-2030,($MILLION)
    TABLE 20. RADIATION ONCOLOGY MARKET FOR GYNECOLOGICAL CANCER BY COUNTRY, 2021-2030,($MILLION)
    TABLE 21. RADIATION ONCOLOGY MARKET REVENUE, FOR OTHERS, BY REGION , 2021-2030,($MILLION)
    TABLE 22. RADIATION ONCOLOGY MARKET FOR OTHERS BY COUNTRY, 2021-2030,($MILLION)
    TABLE 23. RADIATION ONCOLOGY MARKET, BY REGION, 2021-2030,($MILLION)
    TABLE 24. NORTH AMERICA RADIATION ONCOLOGY MARKET, BY TYPE, 2021-2030,($MILLION)
    TABLE 25. NORTH AMERICA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2021-2030,($MILLION)
    TABLE 26. NORTH AMERICA RADIATION ONCOLOGY MARKET, BY COUNTRY, 2021-2030,($MILLION)
    TABLE 27. U.S. RADIATION ONCOLOGY MARKET, BY TYPE, 2021-2030,($MILLION)
    TABLE 28. U.S. RADIATION ONCOLOGY MARKET, BY APPLICATION, 2021-2030,($MILLION)
    TABLE 29. CANADA RADIATION ONCOLOGY MARKET, BY TYPE, 2021-2030,($MILLION)
    TABLE 30. CANADA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2021-2030,($MILLION)
    TABLE 31. MEXICO RADIATION ONCOLOGY MARKET, BY TYPE, 2021-2030,($MILLION)
    TABLE 32. MEXICO RADIATION ONCOLOGY MARKET, BY APPLICATION, 2021-2030,($MILLION)
    TABLE 33. EUROPE RADIATION ONCOLOGY MARKET, BY TYPE, 2021-2030,($MILLION)
    TABLE 34. EUROPE RADIATION ONCOLOGY MARKET, BY APPLICATION, 2021-2030,($MILLION)
    TABLE 35. EUROPE RADIATION ONCOLOGY MARKET, BY COUNTRY, 2021-2030,($MILLION)
    TABLE 36. GERMANY RADIATION ONCOLOGY MARKET, BY TYPE, 2021-2030,($MILLION)
    TABLE 37. GERMANY RADIATION ONCOLOGY MARKET, BY APPLICATION, 2021-2030,($MILLION)
    TABLE 38. UNITED KINGDOM RADIATION ONCOLOGY MARKET, BY TYPE, 2021-2030,($MILLION)
    TABLE 39. UNITED KINGDOM RADIATION ONCOLOGY MARKET, BY APPLICATION, 2021-2030,($MILLION)
    TABLE 40. FRANCE RADIATION ONCOLOGY MARKET, BY TYPE, 2021-2030,($MILLION)
    TABLE 41. FRANCE RADIATION ONCOLOGY MARKET, BY APPLICATION, 2021-2030,($MILLION)
    TABLE 42. SPAIN RADIATION ONCOLOGY MARKET, BY TYPE, 2021-2030,($MILLION)
    TABLE 43. SPAIN RADIATION ONCOLOGY MARKET, BY APPLICATION, 2021-2030,($MILLION)
    TABLE 44. ITALY RADIATION ONCOLOGY MARKET, BY TYPE, 2021-2030,($MILLION)
    TABLE 45. ITALY RADIATION ONCOLOGY MARKET, BY APPLICATION, 2021-2030,($MILLION)
    TABLE 46. REST OF EUROPE RADIATION ONCOLOGY MARKET, BY TYPE, 2021-2030,($MILLION)
    TABLE 47. REST OF EUROPE RADIATION ONCOLOGY MARKET, BY APPLICATION, 2021-2030,($MILLION)
    TABLE 48. ASIA-PACIFIC RADIATION ONCOLOGY MARKET, BY TYPE, 2021-2030,($MILLION)
    TABLE 49. ASIA-PACIFIC RADIATION ONCOLOGY MARKET, BY APPLICATION, 2021-2030,($MILLION)
    TABLE 50. ASIA-PACIFIC RADIATION ONCOLOGY MARKET, BY COUNTRY, 2021-2030,($MILLION)
    TABLE 51. CHINA RADIATION ONCOLOGY MARKET, BY TYPE, 2021-2030,($MILLION)
    TABLE 52. CHINA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2021-2030,($MILLION)
    TABLE 53. JAPAN RADIATION ONCOLOGY MARKET, BY TYPE, 2021-2030,($MILLION)
    TABLE 54. JAPAN RADIATION ONCOLOGY MARKET, BY APPLICATION, 2021-2030,($MILLION)
    TABLE 55. INDIA RADIATION ONCOLOGY MARKET, BY TYPE, 2021-2030,($MILLION)
    TABLE 56. INDIA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2021-2030,($MILLION)
    TABLE 57. SOUTH KOREA RADIATION ONCOLOGY MARKET, BY TYPE, 2021-2030,($MILLION)
    TABLE 58. SOUTH KOREA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2021-2030,($MILLION)
    TABLE 59. AUSTRALIA RADIATION ONCOLOGY MARKET, BY TYPE, 2021-2030,($MILLION)
    TABLE 60. AUSTRALIA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2021-2030,($MILLION)
    TABLE 61. REST OF ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY TYPE, 2021-2030,($MILLION)
    TABLE 62. REST OF ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY APPLICATION, 2021-2030,($MILLION)
    TABLE 63. LAMEA RADIATION ONCOLOGY MARKET, BY TYPE, 2021-2030,($MILLION)
    TABLE 64. LAMEA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2021-2030,($MILLION)
    TABLE 65. LAMEA RADIATION ONCOLOGY MARKET, BY COUNTRY, 2021-2030,($MILLION)
    TABLE 66. BRAZIL RADIATION ONCOLOGY MARKET, BY TYPE, 2021-2030,($MILLION)
    TABLE 67. BRAZIL RADIATION ONCOLOGY MARKET, BY APPLICATION, 2021-2030,($MILLION)
    TABLE 68. SAUDI ARABIA RADIATION ONCOLOGY MARKET, BY TYPE, 2021-2030,($MILLION)
    TABLE 69. SAUDI ARABIA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2021-2030,($MILLION)
    TABLE 70. UAE RADIATION ONCOLOGY MARKET, BY TYPE, 2021-2030,($MILLION)
    TABLE 71. UAE RADIATION ONCOLOGY MARKET, BY APPLICATION, 2021-2030,($MILLION)
    TABLE 72. SOUTH AFRICA RADIATION ONCOLOGY MARKET, BY TYPE, 2021-2030,($MILLION)
    TABLE 73. SOUTH AFRICA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2021-2030,($MILLION)
    TABLE 74. REST OF LAMEA RADIATION ONCOLOGY MARKET, BY TYPE, 2021-2030,($MILLION)
    TABLE 75. REST OF LAMEA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2021-2030,($MILLION)
    TABLE 76.BD: COMPANY SNAPSHOT
    TABLE 77.BD: OPERATING SEGMENTS
    TABLE 78.BD: PRODUCT PORTFOLIO
    TABLE 79.BD: NET SALES,
    TABLE 80.BD: KEY STRATERGIES
    TABLE 81.ISORAY INC.: COMPANY SNAPSHOT
    TABLE 82.ISORAY INC.: OPERATING SEGMENTS
    TABLE 83.ISORAY INC.: PRODUCT PORTFOLIO
    TABLE 84.ISORAY INC.: NET SALES,
    TABLE 85.ISORAY INC.: KEY STRATERGIES
    TABLE 86.PROVISION HEALTHCARE: COMPANY SNAPSHOT
    TABLE 87.PROVISION HEALTHCARE: OPERATING SEGMENTS
    TABLE 88.PROVISION HEALTHCARE: PRODUCT PORTFOLIO
    TABLE 89.PROVISION HEALTHCARE: NET SALES,
    TABLE 90.PROVISION HEALTHCARE: KEY STRATERGIES
    TABLE 91.VARIAN MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT
    TABLE 92.VARIAN MEDICAL SYSTEMS, INC.: OPERATING SEGMENTS
    TABLE 93.VARIAN MEDICAL SYSTEMS, INC.: PRODUCT PORTFOLIO
    TABLE 94.VARIAN MEDICAL SYSTEMS, INC.: NET SALES,
    TABLE 95.VARIAN MEDICAL SYSTEMS, INC.: KEY STRATERGIES
    TABLE 96.ELEKTA AB: COMPANY SNAPSHOT
    TABLE 97.ELEKTA AB: OPERATING SEGMENTS
    TABLE 98.ELEKTA AB: PRODUCT PORTFOLIO
    TABLE 99.ELEKTA AB: NET SALES,
    TABLE 100.ELEKTA AB: KEY STRATERGIES
    TABLE 101.ACCURAY INCORPORATED: COMPANY SNAPSHOT
    TABLE 102.ACCURAY INCORPORATED: OPERATING SEGMENTS
    TABLE 103.ACCURAY INCORPORATED: PRODUCT PORTFOLIO
    TABLE 104.ACCURAY INCORPORATED: NET SALES,
    TABLE 105.ACCURAY INCORPORATED: KEY STRATERGIES
    TABLE 106.MEVION MEDICAL SYSTEMS: COMPANY SNAPSHOT
    TABLE 107.MEVION MEDICAL SYSTEMS: OPERATING SEGMENTS
    TABLE 108.MEVION MEDICAL SYSTEMS: PRODUCT PORTFOLIO
    TABLE 109.MEVION MEDICAL SYSTEMS: NET SALES,
    TABLE 110.MEVION MEDICAL SYSTEMS: KEY STRATERGIES
    TABLE 111.IBA WORLDWIDE: COMPANY SNAPSHOT
    TABLE 112.IBA WORLDWIDE: OPERATING SEGMENTS
    TABLE 113.IBA WORLDWIDE: PRODUCT PORTFOLIO
    TABLE 114.IBA WORLDWIDE: NET SALES,
    TABLE 115.IBA WORLDWIDE: KEY STRATERGIES
    TABLE 116.NORDION (CANADA) INC.: COMPANY SNAPSHOT
    TABLE 117.NORDION (CANADA) INC.: OPERATING SEGMENTS
    TABLE 118.NORDION (CANADA) INC.: PRODUCT PORTFOLIO
    TABLE 119.NORDION (CANADA) INC.: NET SALES,
    TABLE 120.NORDION (CANADA) INC.: KEY STRATERGIES
    TABLE 121.PANACEA MEDICAL TECHNOLOGIES PVT. LTD: COMPANY SNAPSHOT
    TABLE 122.PANACEA MEDICAL TECHNOLOGIES PVT. LTD: OPERATING SEGMENTS
    TABLE 123.PANACEA MEDICAL TECHNOLOGIES PVT. LTD: PRODUCT PORTFOLIO
    TABLE 124.PANACEA MEDICAL TECHNOLOGIES PVT. LTD: NET SALES,
    TABLE 125.PANACEA MEDICAL TECHNOLOGIES PVT. LTD: KEY STRATERGIES
  • LIST OF FIGURES

  • FIGURE 1.RADIATION ONCOLOGY MARKET SEGMENTATION
    FIGURE 2.RADIATION ONCOLOGY MARKET,2021-2030
    FIGURE 3.RADIATION ONCOLOGY MARKET,2021-2030
    FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
    FIGURE 5.PORTER FIVE-1
    FIGURE 6.PORTER FIVE-2
    FIGURE 7.PORTER FIVE-3
    FIGURE 8.PORTER FIVE-4
    FIGURE 9.PORTER FIVE-5
    FIGURE 10.TOP PLAYER POSITIONING
    FIGURE 11.RADIATION ONCOLOGY MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
    FIGURE 12.VALUE CHAIN ANALYSIS
    FIGURE 13.MARKET SHARE ANALYSIS
    FIGURE 14.REGULATORY GUIDELINES
    FIGURE 15.KEY REGULATION ANALYSIS
    FIGURE 16.PATENT ANALYSIS BY COMPANY
    FIGURE 17.PATENT ANALYSIS BY COUNTRY
    FIGURE 18.RADIATION ONCOLOGY MARKET,BY TYPE,2021(%)
    FIGURE 19.COMPARATIVE SHARE ANALYSIS OF EXTERNAL BEAM RADIATION THERAPY RADIATION ONCOLOGY MARKET,2021-2030(%)
    FIGURE 20.COMPARATIVE SHARE ANALYSIS OF INTERNAL BEAM RADIATION THERAPY RADIATION ONCOLOGY MARKET,2021-2030(%)
    FIGURE 21.RADIATION ONCOLOGY MARKET,BY APPLICATION,2021(%)
    FIGURE 22.COMPARATIVE SHARE ANALYSIS OF PROSTATE CANCER RADIATION ONCOLOGY MARKET,2021-2030(%)
    FIGURE 23.COMPARATIVE SHARE ANALYSIS OF BREAST CANCER RADIATION ONCOLOGY MARKET,2021-2030(%)
    FIGURE 24.COMPARATIVE SHARE ANALYSIS OF LUNG CANCER RADIATION ONCOLOGY MARKET,2021-2030(%)
    FIGURE 25.COMPARATIVE SHARE ANALYSIS OF HEAD AND NECK CANCER RADIATION ONCOLOGY MARKET,2021-2030(%)
    FIGURE 26.COMPARATIVE SHARE ANALYSIS OF COLORECTAL CANCER RADIATION ONCOLOGY MARKET,2021-2030(%)
    FIGURE 27.COMPARATIVE SHARE ANALYSIS OF CERVICAL CANCER RADIATION ONCOLOGY MARKET,2021-2030(%)
    FIGURE 28.COMPARATIVE SHARE ANALYSIS OF GYNECOLOGICAL CANCER RADIATION ONCOLOGY MARKET,2021-2030(%)
    FIGURE 29.COMPARATIVE SHARE ANALYSIS OF OTHERS RADIATION ONCOLOGY MARKET,2021-2030(%)
    FIGURE 30.RADIATION ONCOLOGY MARKET BY REGION,2021
    FIGURE 31.U.S. RADIATION ONCOLOGY MARKET,2021-2030($MILLION)
    FIGURE 32.CANADA RADIATION ONCOLOGY MARKET,2021-2030($MILLION)
    FIGURE 33.MEXICO RADIATION ONCOLOGY MARKET,2021-2030($MILLION)
    FIGURE 34.GERMANY RADIATION ONCOLOGY MARKET,2021-2030($MILLION)
    FIGURE 35.UNITED KINGDOM RADIATION ONCOLOGY MARKET,2021-2030($MILLION)
    FIGURE 36.FRANCE RADIATION ONCOLOGY MARKET,2021-2030($MILLION)
    FIGURE 37.SPAIN RADIATION ONCOLOGY MARKET,2021-2030($MILLION)
    FIGURE 38.ITALY RADIATION ONCOLOGY MARKET,2021-2030($MILLION)
    FIGURE 39.REST OF EUROPE RADIATION ONCOLOGY MARKET,2021-2030($MILLION)
    FIGURE 40.CHINA RADIATION ONCOLOGY MARKET,2021-2030($MILLION)
    FIGURE 41.JAPAN RADIATION ONCOLOGY MARKET,2021-2030($MILLION)
    FIGURE 42.INDIA RADIATION ONCOLOGY MARKET,2021-2030($MILLION)
    FIGURE 43.SOUTH KOREA RADIATION ONCOLOGY MARKET,2021-2030($MILLION)
    FIGURE 44.AUSTRALIA RADIATION ONCOLOGY MARKET,2021-2030($MILLION)
    FIGURE 45.REST OF ASIA PACIFIC RADIATION ONCOLOGY MARKET,2021-2030($MILLION)
    FIGURE 46.BRAZIL RADIATION ONCOLOGY MARKET,2021-2030($MILLION)
    FIGURE 47.SAUDI ARABIA RADIATION ONCOLOGY MARKET,2021-2030($MILLION)
    FIGURE 48.UAE RADIATION ONCOLOGY MARKET,2021-2030($MILLION)
    FIGURE 49.SOUTH AFRICA RADIATION ONCOLOGY MARKET,2021-2030($MILLION)
    FIGURE 50.REST OF LAMEA RADIATION ONCOLOGY MARKET,2021-2030($MILLION)
    FIGURE 51. TOP WINNING STRATEGIES, BY YEAR
    FIGURE 52. TOP WINNING STRATEGIES, BY DEVELOPMENT
    FIGURE 53. TOP WINNING STRATEGIES, BY COMPANY
    FIGURE 54.PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 55.COMPETITIVE DASHBOARD
    FIGURE 56.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
    FIGURE 57.BD.: NET SALES ,($MILLION)
    FIGURE 58.ISORAY INC..: NET SALES ,($MILLION)
    FIGURE 59.PROVISION HEALTHCARE.: NET SALES ,($MILLION)
    FIGURE 60.VARIAN MEDICAL SYSTEMS, INC..: NET SALES ,($MILLION)
    FIGURE 61.ELEKTA AB.: NET SALES ,($MILLION)
    FIGURE 62.ACCURAY INCORPORATED.: NET SALES ,($MILLION)
    FIGURE 63.MEVION MEDICAL SYSTEMS.: NET SALES ,($MILLION)
    FIGURE 64.IBA WORLDWIDE.: NET SALES ,($MILLION)
    FIGURE 65.NORDION (CANADA) INC..: NET SALES ,($MILLION)
    FIGURE 66.PANACEA MEDICAL TECHNOLOGIES PVT. LTD.: NET SALES ,($MILLION)

 
 

Increase in prevalence of cancer due to unhealthy lifestyle and rising intake of carcinogenic food worldwide is the key factor that is projected to drive the growth of global radiation oncology market during the forecast period. In addition, technological advancements in radiation oncology like image-guided and intensity-modulated radiation therapy, digital imaging, and computer-controlled linear accelerators are expected to fuel the growth of the market in forecasted period. However, high costs of treatment and rise of new technological errors are expected to hamper the growth of the market growth during the forecasted period. On the contrary, rising mortality rate due to cancer and the need for effective treatment are anticipated to provide opportunities to key players to maintain pace of radiation oncology market in the upcoming years.

Among the analyzed regions, North America is expected to account for the highest revenue in the market in the forecasted years, followed by Europe, Asia-Pacific, LAMEA. North America has the most developed and advanced healthcare infrastructure which is influencing the adoption of radiation oncology techniques by cancer patients.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. Increasing prevalence and mortality rate of cancer patients, changes in lifestyle & increase in consumption of highly processed foods along with technological advancements in technology like image guided and intensity modulated radiation therapy, digital imaging, and computer controlled linear accelerators are considered to be the drivers of the global radiation oncology market.

A. Breast Cancer sub-segment of the application wise industry acquired the maximum share of the global radiation oncology Market in 2021.

A. The key players of the market like Panacea Medical Technologies have started taking certifications on the latest technologies which are making them reliable.

A. North America will provide more business opportunities for the Global Radiation Oncology Market in future.

A. The key players in the global radiation oncology market are Varian Medical Systems, Inc., Elekta AB, Accuray Incorporated, Mevion Medical Systems, IBA Worldwide, Nordion (Canada) Inc., BD, Isoray Inc., Provision Healthcare, and Panacea Medical Technologies Pvt. Ltd Radiation Oncology Market.

A. The major growth strategies adopted by global radiation oncology market players are expansion of businesses in developing countries and certification for advanced technologies.

A. Super specialty hospitals and radiotherapists are the major customers in the global radiation oncology market.

A. The report provides an extensive qualitative and quantitative analysis of the current trends and future estimations of the global radiation oncology market from 2021 to 2030 to determine the prevailing opportunities.

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Sample
RELATED TAGS

Purchase Full Report of
Radiation Oncology Market

Start reading instantly.
This Report and over 66,944+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Jul 2023 - Jul 2024)
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jul 2023 - Jul 2024)
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jul 2023 - Jul 2024)
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jul 2023 - Jul 2024)
  • Enterprise
    License/PDF

  • $9,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jul 2023 - Jul 2024)
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers